UP - logo
E-resources
Full text
Peer reviewed
  • Thrombolysis and thrombecto...
    Diener, HC; Bernstein, R; Butcher, K; Campbell, B; Cloud, G; Davalos, A; Davis, S; Ferro, JM; Grond, M; Krieger, D; Ntaios, G; Slowik, A; Touzé, E

    International journal of stroke, 01/2017, Volume: 12, Issue: 1
    Journal Article

    Systemic thrombolysis with rt-PA is contraindicated in patients with acute ischemic stroke anticoagulated with dabigatran. This expert opinion provides guidance on the use of the specific reversal agent idarucizumab followed by rt-PA and/or thrombectomy in patients with ischemic stroke pre-treated with dabigatran. The use of idarucizumab followed by rt-PA is covered by the label of both drugs.